By far, the major thrust of pharmaceutical research at this time is aimed at cancer. In 2102, a record eleven oncology drugs were approved by the FDA. Unfortunately, most advances have been incremental, and cures for most previously incurable cancers remain elusive.
By far, the major thrust of pharmaceutical research at this time is aimed at cancer. In 2102, a record eleven oncology drugs were approved by the FDA. Unfortunately, most advances have been incremental, and cures for most previously incurable cancers remain elusive.